Sunshine Biopharma (OTCMKTS:SBFM) Stock In Focus After Announcing a Patent Application
Sunshine Biopharma (OTCMKTS:SBFM) has just filed a patent application for a potential new treatment for neurodegenerative disorders. It includes experimental results that show certain mRNA molecules provide protective effects against oxidative stress in differentiated neuronal cells. It is a process that mimics neuronal degeneration. Neurodegeneration happens when there is progressive loss of neuronal function – it could eventually result in cell death. Amyotrophic lateral sclerosis (ALS), Parkinson’s disease, multiple sclerosis,…